Description

GC Corp. is engaged in the manufacture of pharmaceutical products and oversees the establishment and coordination of business strategies for Green Cross subsidiaries, including business launch and investment portfolio management. The company's prescription drug portfolio includes blood derivatives, cerebrovascular disease treatments, fibrinolytic agents, vaccines, hunter syndrome therapies, herbal medicines, and recombinant products. It also offers over-the-counter drugs such as skin disease treatments and topical non-steroidal anti-inflammatories. GC Corp. was founded on October 5, 1967, and is headquartered in Yongin-si, South Korea.